electroCore, Inc. to Present at the Evercore ISI HealthCONx Conference

NEXT STORY
UPDATE – BriaCell to Present Updated Clinical Data Including Early Safety Data in KEYTRUDA® Combination Study and Positive Phase IIa Monotherapy Efficacy Data at 2018 San Antonio Breast Cancer Symposium
PREV STORY
Integra® XT Revision Total Ankle Replacement System Offers Innovative Solution to Ankle Arthroplasty Revision Surgery
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

U.S. FDA Accepts for Priority Review Supplemental New Drug Application for Oxbryta® (voxelotor) for the Treatment of Sickle Cell Disease in Children Ages 4 to 11

author_avatar
NASDAQ Market News

European Drug Discovery Industry to 2030 – Featuring Bayer, Novartis and Pfizer Among Others

author_avatar
NASDAQ Market News

Myovant Sciences Announces Closing of $400 Million Loan Facility, Repayment of Debt, Board of Director Transitions, and Executive Promotions

author_avatar
NASDAQ Market News